Cited by

• Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

  Charney AW, Ruderfer DM, Stahl EA, Moran JL, Chambert K, Belliveau RA, Forty L, Gordon-Smith K, Di Florio A, Lee PH, Bromet EJ, Buckley PF, Escamilla MA, Fanous AH, Fochtmann LJ, Lehrer DS, Malaspina D, Marder SR, Morley CP, Nicolini H, Perkins DO, Rakofsky JJ, Rapaport MH, Medeiros H, Sobell JL, Green EK, Backlund L, Bergen SE, Juréus A, Schalling M, Lichtenstein P, Roussos P, Knowles JA, Jones I, Jones LA, Hultman CM, Perlis RH, Purcell SM, McCarroll SA, Pato CN, Pato MT, Craddock N, Landén M, Smoller JW, Sklar P. Charney AW, et al. Transl Psychiatry. 2017 Jan 10;7(1):e993. doi: 10.1038/tp.2016.242. Transl Psychiatry. 2017. PMID: 28072414 Free PMC article.
• Functional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources?

  Onofrj M, Ajdinaj P, Digiovanni A, Malek N, Martinotti G, Ferro FM, Russo M, Thomas A, Sensi SL. Onofrj M, et al. Front Psychiatry. 2023 Mar 17;14:1120981. doi: 10.3389/fpsyt.2023.1120981. eCollection 2023. Front Psychiatry. 2023. PMID: 37009111 Free PMC article. Review.
• On the diagnostic and neurobiological origins of bipolar disorder.

  Charney AW, Mullins N, Park YJ, Xu J. Charney AW, et al. Transl Psychiatry. 2020 Apr 23;10(1):118. doi: 10.1038/s41398-020-0796-8. Transl Psychiatry. 2020. PMID: 32327632 Free PMC article. Review.
• The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

  Fountoulakis KN, Young A, Yatham L, Grunze H, Vieta E, Blier P, Moeller HJ, Kasper S. Fountoulakis KN, et al. Int J Neuropsychopharmacol. 2017 Feb 1;20(2):98-120. doi: 10.1093/ijnp/pyw091. Int J Neuropsychopharmacol. 2017. PMID: 27815414 Free PMC article. Review.